Relay Therapeutics, Inc. RLAY Weighted Average Number Of Shares Outstanding Diluted
Weighted Average Number Of Shares Outstanding Diluted at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept rlay:WeightedAverageNumberOfSharesOutstandingDiluted.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s weighted average number of shares outstanding diluted.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s weighted average number of shares outstanding diluted?
- Relay Therapeutics, Inc. (RLAY) reported weighted average number of shares outstanding diluted of 179.8M in Q1 2026.
- How has Relay Therapeutics, Inc.'s weighted average number of shares outstanding diluted changed year-over-year?
- Relay Therapeutics, Inc.'s weighted average number of shares outstanding diluted increased by 6.3% year-over-year, from 169.2M to 179.8M.
- What is the long-term trend for Relay Therapeutics, Inc.'s weighted average number of shares outstanding diluted?
- Over 2 years (2023 to 2025), Relay Therapeutics, Inc.'s weighted average number of shares outstanding diluted has grown at a 18.5% compound annual growth rate (CAGR), from 487.8M to 684.5M.
- What does weighted average number of shares outstanding diluted mean?
- This metric represents the average number of common shares outstanding during the reporting period, adjusted for the potential dilutive effect of stock options, warrants, and convertible securities. It is the standard denominator used to calculate diluted earnings per share, reflecting the total potential equity ownership. This figure is essential for assessing the impact of equity-based compensation and capital structure on shareholder value.